Błonica – Rokowania, prognozy i postęp choroby

Błonica
Rokowania, prognozy i postęp choroby

Błonica, wywoływana przez toksynotwórcze szczepy Corynebacterium diphtheriae i rzadziej C. ulcerans, pozostaje chorobą o wysokiej śmiertelności, sięgającej około 10%, a w grupach wysokiego ryzyka (dzieci <5 lat, osoby >40 lat, nieleczone) nawet do 50%. Kluczowe dla rokowania są status szczepienia oraz czas rozpoczęcia leczenia antytoksyną błoniczą (DAT), gdzie opóźnienie powyżej 4 dni znacząco zwiększa śmiertelność (z 4,2% do 24%). Zajęcie układu sercowo-naczyniowego, zwłaszcza obecność bloku przedsionkowo-komorowego, bloku lewej odnogi pęczka Hisa oraz zaburzeń rytmu komorowego, jest główną przyczyną zgonów, z ryzykiem śmiertelności około 50%. Charakterystyczne cechy kliniczne pogarszające rokowanie to rozległa błona rzekoma, obrzęk tkanek szyi („szyja bycza”), zapalenie mięśnia sercowego oraz podwyższony poziom enzymu AST.

Prognozy błonicy (ang. Diphtheria Prognosis)

Błonica jest chorobą zagrażającą życiu, wywoływaną przez toksynotwórcze szczepy bakterii Corynebacterium diphtheriae (w niektórych przypadkach również przez Corynebacterium ulcerans), które kolonizują błony śluzowe. Choroba ta, mimo dostępnych metod leczenia i zapobiegania, nadal może prowadzić do poważnych powikłań i śmierci.¹²

Wskaźniki śmiertelności

Śmiertelność w przypadku błonicy pozostaje stosunkowo wysoka i nie uległa znaczącym zmianom na przestrzeni ostatnich 100 lat, utrzymując się na poziomie około 10%. W grupach wysokiego ryzyka wskaźniki te są jeszcze wyższe:³⁴

Dzieci poniżej 5 roku życia – śmiertelność do 20%
Osoby powyżej 40 roku życia – podwyższone ryzyko zgonu
Osoby nieleczone – śmiertelność około 50%

⁵⁶⁷

Warto podkreślić, że nawet przy zastosowaniu właściwego leczenia, około 5-10% pacjentów umiera z powodu powikłań błonicy. Jednakże szczepienia mogą niemal całkowicie wyeliminować ryzyko zgonu, redukując zapadalność do około 1% i praktycznie zerowej śmiertelności.⁸⁹

Czynniki wpływające na prognozę

Rokowanie w błonicy zależy od wielu czynników, które determinują przebieg choroby i prawdopodobieństwo wystąpienia powikłań:¹⁰¹¹

Status szczepień

Status szczepienia pacjenta jest jednym z najważniejszych czynników wpływających na rokowanie. Osoby zaszczepione mają znacznie niższe ryzyko rozwoju ciężkiej postaci choroby oraz zgonu. Badania wskazują, że w regionach o wysokim (80%) i niskim (25%) poziomie wyszczepialności obserwuje się niższe szacunki ryzyka błonicy, choć może to być częściowo związane z niedoszacowaniem rzeczywistego obciążenia chorobą w środowiskach o ograniczonych zasobach.¹²¹³

Czas trwania choroby i moment rozpoczęcia leczenia

Wczesne rozpoznanie i rozpoczęcie leczenia ma kluczowe znaczenie dla przeżycia pacjenta. Przypadki z czasem trwania objawów przekraczającym 4 dni wiążą się z podwyższoną śmiertelnością. Opóźnienie w podaniu antytoksyny błoniczej (DAT) każdego dnia zwiększa wskaźniki śmiertelności – z 4,2% w przypadku leczenia w ciągu pierwszych 2 dni do 24% w przypadku rozpoczęcia leczenia piątego dnia choroby.¹⁴¹⁵¹⁶

Obecność powikłań kardiologicznych

Zajęcie układu sercowo-naczyniowego jest najczęstszą przyczyną zgonów w błonicy, występującą u 10-30% pacjentów. Dla osób z powikłaniami kardiologicznymi prawdopodobieństwo zgonu wynosi około 50%. Szczególnie niekorzystnym rokowniczo czynnikiem jest obecność:¹⁷¹⁸

Bloku przedsionkowo-komorowego
Bloku lewej odnogi pęczka Hisa
Zaburzeń rytmu komorowego przy przyjęciu

¹⁹²⁰²¹

Zaangażowanie systemowe

Systemowe rozprzestrzenianie się toksyny błoniczej jest istotnym predyktorem wysokiej śmiertelności. Toksyna błonicza może przedostawać się do układu krążenia i tkanek, powodując rozległe uszkodzenia narządów, w tym powikłania neurologiczne, takie jak polineuropatia czy porażenie.²²²³²⁴

Obraz kliniczny

Niektóre cechy kliniczne są związane z gorszym rokowaniem:²⁵²⁶

Rozległa błona rzekoma w gardle
Obecność „szyi byczej” (obrzęk tkanek szyi)
Zapalenie mięśnia sercowego widoczne przy przyjęciu
Podwyższony poziom enzymu AST

Metody monitorowania i ich wpływ na prognozę

Nowoczesne metody diagnostyczne i monitorujące mogą znacząco poprawić rokowanie w błonicy poprzez wczesne wykrywanie dysfunkcji serca i subklinicznych zaburzeń rytmu:²⁷

Inwazyjne monitorowanie ciśnienia krwi
Ciągłe monitorowanie EKG
Seryjne badania echokardiograficzne przyłóżkowe
Standardowe monitorowanie kliniczne

Zaleca się kontynuowanie ścisłego monitorowania hemodynamicznego aż do momentu, gdy można zaobserwować powrót funkcji mięśnia sercowego w badaniu echokardiograficznym. Wczesne wykrycie zaburzeń umożliwia szybką interwencję, co może zmniejszyć ryzyko ciężkich, zagrażających życiu powikłań.²⁸

Wpływ konfliktów zbrojnych na ryzyko i rokowanie błonicy

Niedawne badania wskazują na związek między występowaniem konfliktów zbrojnych a ryzykiem wystąpienia błonicy. Lokalna historia poważnych konfliktów zbrojnych, oceniana na podstawie liczby ofiar śmiertelnych, jest związana z późniejszymi doniesieniami o występowaniu błonicy w Afryce w latach 2017-2024.²⁹³⁰

Czynniki związane z konfliktami wpływające na prognozę błonicy to:³¹³²

Niższy poziom wyszczepialności na obszarach dotkniętych konfliktem
Ograniczony dostęp do opieki zdrowotnej
Opóźnione rozpoznanie i leczenie
Trudności w monitorowaniu populacji i prowadzeniu nadzoru epidemiologicznego

Dane dotyczące niedawnych konfliktów zbrojnych mogą być pomocne w planowaniu działań w zakresie zdrowia publicznego, szczególnie na obszarach o ograniczonym dostępie do danych dotyczących wyszczepialności.³³

Nowoczesne podejścia terapeutyczne i ich wpływ na rokowanie

Trwają prace nad nowymi metodami terapeutycznymi, które mogą poprawić rokowanie w błonicy:³⁴

Przeciwciała neutralizujące toksynę

Badania nad ludzkimi przeciwciałami monoklonalnymi neutralizującymi toksynę błoniczą wykazują obiecujące wyniki. Niektóre kombinacje przeciwciał osiągają aktywność neutralizującą na poziomie 79 IU/mg. Specyficzna aktywność najlepszych neutralizujących ludzkich przeciwciał monoklonalnych przekracza (około 10-krotnie) siłę działania przeciwciała monoklonalnego szczura, które zostało uwzględnione w badaniu.³⁵

Te przeciwciała są obiecującymi kandydatami do przyszłego rozwoju regulacyjnego i klinicznego jako alternatywa dla końskiej antytoksyny błoniczej (DAT) w terapii błonicy, co może znacząco wpłynąć na poprawę dostępności leczenia, szczególnie w kontekście globalnego niedoboru DAT.³⁶³⁷

Podsumowanie czynników prognostycznych

Rokowanie w błonicy jest zależne od złożonej interakcji wielu czynników. Poniżej przedstawiono główne determinanty prognostyczne:³⁸³⁹

Czynniki demograficzne: wiek (poniżej 5 lat i powyżej 40 lat związany z gorszym rokowaniem)
Status immunologiczny: wcześniejsze szczepienie znacząco poprawia rokowanie
Czas do diagnozy i leczenia: wczesne rozpoznanie i terapia to kluczowe czynniki poprawiające przeżywalność
Zaangażowanie narządowe: zajęcie serca, nerek i układu nerwowego pogarsza rokowanie
Obraz kliniczny: rozległa błona rzekoma i „szyja bycza” są związane z gorszym rokowaniem
Dostęp do zaawansowanych metod monitorowania: wpływa na wczesne wykrywanie powikłań
Dostępność specjalistycznego leczenia: szybki dostęp do antytoksyny błoniczej i odpowiedniej antybiotykoterapii

Warto podkreślić, że pomimo dostępnych metod leczenia, rekonwalescencja po błonicy jest często powolna, szczególnie w przypadkach z powikłaniami kardiologicznymi i neurologicznymi.⁴⁰

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

Materiały źródłowe

#1 Factsheet about diphtheria
https://www.ecdc.europa.eu/en/diphtheria/facts
Diphtheria is an acute disease caused by toxin-producing strains of Corynebacterium diphtheriae (in some cases also by Corynebacterium ulcerans) bacteria, that is known to colonise mucous membranes. […] In non-vaccinated individuals, and especially if proper treatment is delayed, death can occur in up to 10% of clinical cases despite antibiotics and the use of anti-sera. […] Diphtheria can cause toxins to be released into the circulatory system and tissues that can cause extensive organ damage. Complications affecting the heart and neurological complications, such as paralysis, can develop. The most common cause of death is suffocation by aspiration of the membrane.
#2 Novel Clinical Monitoring Approaches for Reemergence of Diphtheria Myocarditis, Vietnam – Volume 28, Number 2âFebruary 2022 – Emerging Infectious Diseases journal – CDC
https://wwwnc.cdc.gov/eid/article/28/2/21-0555_article
Diphtheria is a life-threatening, vaccine-preventable disease caused by toxigenic Corynebacterium bacterial species that continues to cause substantial disease and death worldwide, particularly in vulnerable populations. […] Severe diphtheria is usually associated with cardiac and neurologic complications because of the high affinity of diphtheria toxin with theses tissues. […] Antitoxin is considered the cornerstone of the prevention of severe complications and death and should be readily available. […] However, a global shortage of diphtheria antitoxin (DAT) is ongoing, which hinders availability in low-resource settings. […] Managing diphtheria includes early use of DAT and antibiotics. Mortality rates increase daily with delays in DAT administration, from 4.2% if the disease is treated in the first 2 days to 24% by the fifth day of illness.
#3 Corynebacterium Diphtheriae (Diptheria) – MD Searchlight
https://mdsearchlight.com/infectious-disease/corynebacterium-diphtheriae-diptheria/
Diphtheria is a dangerous disease that primarily affects the upper respiratory tract and can be prevented with a vaccine. […] The death rate from diphtheria has not changed much over the past 100 years, staying steady around 10%. The main reason why patients with diphtheria die is due to heart-related problems, which 10-30% of diphtheria patients develop. Unfortunately, for those affected by these heart complications, the likelihood of death is around 50%. […] There are a number of factors that can affect the outcome of the disease. For example, whether the patient has been vaccinated, how long theyâve had symptoms, and when they were diagnosed can all influence how severe the disease becomes. […] One study from 2004, which looked at 154 Vietnamese children with diphtheria, found that an extensive pseudomembrane and bull neck appearance are both strong signs that the child may develop serious heart problems due to diphtheria and therefore have a worse prognosis.
#4 Diphtheria – Symptoms & causes – Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/diphtheria/symptoms-causes/syc-20351897
Diphtheria can be treated with medications. But in advanced stages, diphtheria can damage the heart, kidneys and nervous system. Even with treatment, diphtheria can be deadly, especially in children. […] With treatment, most people with diphtheria survive these complications, but recovery is often slow. Diphtheria is fatal about 5% to 10% of the time. Rates of death are higher in children under age 5 or adults older than age 40.
#5 Human antibodies neutralizing diphtheria toxin in vitro and in vivo | Scientific Reports
https://www.nature.com/articles/s41598-019-57103-5
Diphtheria is fatal in 5-10% of cases, but children under the age of five have a mortality rate of up to 20%. […] Treatment involves antibiotics to kill the bacteria (erythromycin or penicillin for 14 days) and administering of diphtheria antitoxin (DAT) to neutralize the effects of the toxin. […] The individual antibodies did not show a high level of neutralization, whereas all antibody pairs and the triple antibody combination resulted in a neutralization potency of 79 IU/mg. […] The neutralization efficacy of the scFv-Fcs and IgGs were first analyzed in vitro using the Vero cell toxin neutralization assay. […] The specific activity of the best neutralizing human monoclonal antibodies from our studies in the Vero cell TNT also exceeded (approximately 10-fold) the potency of a rat monoclonal antibody that was included in our study. […] The antibodies described here are promising candidates for future regulatory and clinical development as an alternative to equine DAT for diphtheria therapy.
#6 Diphtheria: Causes, Symptoms, Treatment & Prevention
https://my.clevelandclinic.org/health/diseases/17870-diphtheria
Treatment for diphtheria can be effective. But, even with treatment, roughly 1 out of 10 people might die. For those without treatment, one out of two patients may die. Vaccination is the best choice. If you haven’t been vaccinated, make an appointment with your healthcare provider. […] Yes. When treated immediately, diphtheria is managed successfully with antitoxins and antibiotics. Vaccination can prevent diphtheria altogether.
#7 Diphtheria – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK560911/
The prognosis of diphtheria is influenced by several factors: […] High mortality rates are observed in individuals younger than 5 and those older than 40. […] Cases with an onset duration exceeding 4 days are associated with elevated mortality. […] Cardiovascular involvement, particularly atrioventricular and left bundle-branch blocks, is associated with a poor prognosis. […] Systemic involvement is a significant predictor of high mortality rates.
#8
https://books.openedition.org/obp/1978?lang=en
Diphtheria levies a toll of clinical incidence of 10% of all born with a mortality of 5 to 7 per 1000; immunisation reduces this to an incidence of 1% and zero mortality. […] Early on it was realised that to be effective the antitoxin had to be administered early, since the toxin could only be neutralised before it became bound to the tissue elements where it caused toxicity. […] The number of fatal cases is less when antitoxin is used early in the illness than in those that do not receive it until a later period. […] The success of the many local experiments into the protection offered by diphtheria immunisation means there can be no doubt that this technique is effective in reducing the incidence and mortality of the disease. […] It is thus possible that a concurrent change may have taken place in the pathogenicity of Corynebacterium diphtheriae, or human resistance may have increased. […] The occasional case of diphtheria that occurs intermittently in Europe, serious as each is, serves as a reminder of how far we have progressed from the dire situation in the diphtheria wards one hundred years ago.
#9 Diphtheria – Symptoms & causes – Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/diphtheria/symptoms-causes/syc-20351897
Diphtheria can be treated with medications. But in advanced stages, diphtheria can damage the heart, kidneys and nervous system. Even with treatment, diphtheria can be deadly, especially in children. […] With treatment, most people with diphtheria survive these complications, but recovery is often slow. Diphtheria is fatal about 5% to 10% of the time. Rates of death are higher in children under age 5 or adults older than age 40.
#10 Corynebacterium Diphtheriae (Diptheria) – MD Searchlight
https://mdsearchlight.com/infectious-disease/corynebacterium-diphtheriae-diptheria/
Diphtheria is a dangerous disease that primarily affects the upper respiratory tract and can be prevented with a vaccine. […] The death rate from diphtheria has not changed much over the past 100 years, staying steady around 10%. The main reason why patients with diphtheria die is due to heart-related problems, which 10-30% of diphtheria patients develop. Unfortunately, for those affected by these heart complications, the likelihood of death is around 50%. […] There are a number of factors that can affect the outcome of the disease. For example, whether the patient has been vaccinated, how long theyâve had symptoms, and when they were diagnosed can all influence how severe the disease becomes. […] One study from 2004, which looked at 154 Vietnamese children with diphtheria, found that an extensive pseudomembrane and bull neck appearance are both strong signs that the child may develop serious heart problems due to diphtheria and therefore have a worse prognosis.
#11 Diphtheria – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK560911/
The prognosis of diphtheria is influenced by several factors: […] High mortality rates are observed in individuals younger than 5 and those older than 40. […] Cases with an onset duration exceeding 4 days are associated with elevated mortality. […] Cardiovascular involvement, particularly atrioventricular and left bundle-branch blocks, is associated with a poor prognosis. […] Systemic involvement is a significant predictor of high mortality rates.
#12
https://link.springer.com/article/10.1186/s44263-025-00156-8
Diphtheria has been re-emerging around the world at alarming rates, raising concerns about emergency preparedness, especially when global supplies of life-saving diphtheria antitoxin are insufficient. […] This exploratory analysis indicates that conflict-related fatalities are potentially helpful indicators of subnational diphtheria risk in countries in the WHO African region from 2017 to 2024. […] The best-fitting model also associated lower estimates of diphtheria risk in areas with high (80%) and low (25%) vaccine coverage, though this is possibly due to underreporting of the true burden of disease in low-resource settings. […] We found that a local history of severe armed conflict, as assessed by the number of resulting fatalities, is associated with subsequent reports of diphtheria presence in Africa from 2017 to 2024 and should be considered as a potential early signal of increased outbreak risk.
#13
https://link.springer.com/article/10.1186/s44263-025-00156-8
Evidence from our analyses supports hypotheses that conflict can increase the risk of diphtheria both through lower vaccination coverage as well as via an independent mechanism. […] Although high levels of childhood DTP3 vaccine coverage were protective against the presence of reported diphtheria cases, we found that the relationship was somewhat complex, with estimated diphtheria risk peaking around 50% DTP3 coverage. […] Because of this, we suggest that the history and severity of armed conflict may be an early indicator of increased risk of diphtheria if local vaccination coverage data are unavailable, as is often the case in low-resource settings.
#14 Novel Clinical Monitoring Approaches for Reemergence of Diphtheria Myocarditis, Vietnam – Volume 28, Number 2âFebruary 2022 – Emerging Infectious Diseases journal – CDC
https://wwwnc.cdc.gov/eid/article/28/2/21-0555_article
Diphtheria is a life-threatening, vaccine-preventable disease caused by toxigenic Corynebacterium bacterial species that continues to cause substantial disease and death worldwide, particularly in vulnerable populations. […] Severe diphtheria is usually associated with cardiac and neurologic complications because of the high affinity of diphtheria toxin with theses tissues. […] Antitoxin is considered the cornerstone of the prevention of severe complications and death and should be readily available. […] However, a global shortage of diphtheria antitoxin (DAT) is ongoing, which hinders availability in low-resource settings. […] Managing diphtheria includes early use of DAT and antibiotics. Mortality rates increase daily with delays in DAT administration, from 4.2% if the disease is treated in the first 2 days to 24% by the fifth day of illness.
#15 Diphtheria – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK560911/
The prognosis of diphtheria is influenced by several factors: […] High mortality rates are observed in individuals younger than 5 and those older than 40. […] Cases with an onset duration exceeding 4 days are associated with elevated mortality. […] Cardiovascular involvement, particularly atrioventricular and left bundle-branch blocks, is associated with a poor prognosis. […] Systemic involvement is a significant predictor of high mortality rates.
#16
https://books.openedition.org/obp/1978?lang=en
Diphtheria levies a toll of clinical incidence of 10% of all born with a mortality of 5 to 7 per 1000; immunisation reduces this to an incidence of 1% and zero mortality. […] Early on it was realised that to be effective the antitoxin had to be administered early, since the toxin could only be neutralised before it became bound to the tissue elements where it caused toxicity. […] The number of fatal cases is less when antitoxin is used early in the illness than in those that do not receive it until a later period. […] The success of the many local experiments into the protection offered by diphtheria immunisation means there can be no doubt that this technique is effective in reducing the incidence and mortality of the disease. […] It is thus possible that a concurrent change may have taken place in the pathogenicity of Corynebacterium diphtheriae, or human resistance may have increased. […] The occasional case of diphtheria that occurs intermittently in Europe, serious as each is, serves as a reminder of how far we have progressed from the dire situation in the diphtheria wards one hundred years ago.
#17 Corynebacterium Diphtheriae (Diptheria) – MD Searchlight
https://mdsearchlight.com/infectious-disease/corynebacterium-diphtheriae-diptheria/
Diphtheria is a dangerous disease that primarily affects the upper respiratory tract and can be prevented with a vaccine. […] The death rate from diphtheria has not changed much over the past 100 years, staying steady around 10%. The main reason why patients with diphtheria die is due to heart-related problems, which 10-30% of diphtheria patients develop. Unfortunately, for those affected by these heart complications, the likelihood of death is around 50%. […] There are a number of factors that can affect the outcome of the disease. For example, whether the patient has been vaccinated, how long theyâve had symptoms, and when they were diagnosed can all influence how severe the disease becomes. […] One study from 2004, which looked at 154 Vietnamese children with diphtheria, found that an extensive pseudomembrane and bull neck appearance are both strong signs that the child may develop serious heart problems due to diphtheria and therefore have a worse prognosis.
#18 Diphtheria – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK560911/
The prognosis of diphtheria is influenced by several factors: […] High mortality rates are observed in individuals younger than 5 and those older than 40. […] Cases with an onset duration exceeding 4 days are associated with elevated mortality. […] Cardiovascular involvement, particularly atrioventricular and left bundle-branch blocks, is associated with a poor prognosis. […] Systemic involvement is a significant predictor of high mortality rates.
#19 Diphtheria | Nature Reviews Disease Primers
https://www.nature.com/articles/s41572-019-0131-y
Jayashree, M., Shruthi, N. Singhi, S. Predictors of outcome in patients with diphtheria receiving intensive care. Indian Pediatr. 43, 155160 (2006). […] Stockins, B. A., Lanas, F. T., Saavedra, J. G. Opazo, J. A. Prognosis in patients with diphtheric myocarditis and bradyarrhythmias: assessment of results of ventricular pacing. Heart 72, 190191 (1994). […] Manikyamba, D., Satyavani, A. Deepa, P. Diphtheritic polyneuropathy in the wake of resurgence of diphtheria. J. Pediatr. Neurosci. 10, 331 (2015). Together with reference 222, this report describes the importance of polyneuropathy as one of the most severe complications of diphtheria due to the spread of the toxin. […] Havaldar, P. V., Sankpal, M. N. Doddannavar, R. P. Diphtheritic myocarditis: clinical and laboratory parameters of prognosis and fatal outcome. Ann. Trop. Paediatr. 20, 209215 (2016).
#20 Diphtheria | Nature Reviews Disease Primers
https://www.nature.com/articles/s41572-019-0131-y
Lumio, J. T., Groundstroem, K. W. E., Melnick, O. B., Huhtala, H. Rakhmanova, A. G. Electrocardiographic abnormalities in patients with diphtheria: a prospective study. Am. J. Med. 116, 7883 (2004). This article provides a comprehensive information on cardiac involvement in respiratory diphtheria, especially in older patients. […] Samdani, S., Jain, A., Meena, V. Meena, C. B. Cardiac complications in diphtheria and predictors of outcomes. Int. J. Pediatr. Otorhinolaryngol. 104, 7678 (2018).
#21 Novel Clinical Monitoring Approaches for Reemergence of Diphtheria Myocarditis, Vietnam – Volume 28, Number 2âFebruary 2022 – Emerging Infectious Diseases journal – CDC
https://wwwnc.cdc.gov/eid/article/28/2/21-0555_article
Diphtheria myocarditis occurs in 10%20% of respiratory diphtheria, although this figure is likely underestimated because cardiac screening is lacking in many endemic settings. […] The presence of a bull neck and the amount of pharyngeal pseudomembrane at admission are potential risk factors for cardiomyopathy. […] The utility of modern diagnostic and monitoring methods, such as invasive blood pressure monitoring, continuous ECG monitoring, and point-of-care echocardiography, could also improve diagnosis and management through earlier detection of cardiac dysfunction and subclinical rhythm disturbances. […] Ventricular ectopics at admission are predictive of poor outcomes. […] We therefore recommend continuing close hemodynamic monitoring until myocardial functional recovery can be visualized on echocardiographic examination. […] Serial point-of-care echocardiography, where available, together with serial ECGs and standard-of-care clinical monitoring, should be used in the treatment of all hospitalized patients with diphtheria myocarditis to enable timely intervention to mitigate severe and life-threatening consequences.
#22 Diphtheria – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK560911/
The prognosis of diphtheria is influenced by several factors: […] High mortality rates are observed in individuals younger than 5 and those older than 40. […] Cases with an onset duration exceeding 4 days are associated with elevated mortality. […] Cardiovascular involvement, particularly atrioventricular and left bundle-branch blocks, is associated with a poor prognosis. […] Systemic involvement is a significant predictor of high mortality rates.
#23 Factsheet about diphtheria
https://www.ecdc.europa.eu/en/diphtheria/facts
Diphtheria is an acute disease caused by toxin-producing strains of Corynebacterium diphtheriae (in some cases also by Corynebacterium ulcerans) bacteria, that is known to colonise mucous membranes. […] In non-vaccinated individuals, and especially if proper treatment is delayed, death can occur in up to 10% of clinical cases despite antibiotics and the use of anti-sera. […] Diphtheria can cause toxins to be released into the circulatory system and tissues that can cause extensive organ damage. Complications affecting the heart and neurological complications, such as paralysis, can develop. The most common cause of death is suffocation by aspiration of the membrane.
#24 Diphtheria | Nature Reviews Disease Primers
https://www.nature.com/articles/s41572-019-0131-y
Jayashree, M., Shruthi, N. Singhi, S. Predictors of outcome in patients with diphtheria receiving intensive care. Indian Pediatr. 43, 155160 (2006). […] Stockins, B. A., Lanas, F. T., Saavedra, J. G. Opazo, J. A. Prognosis in patients with diphtheric myocarditis and bradyarrhythmias: assessment of results of ventricular pacing. Heart 72, 190191 (1994). […] Manikyamba, D., Satyavani, A. Deepa, P. Diphtheritic polyneuropathy in the wake of resurgence of diphtheria. J. Pediatr. Neurosci. 10, 331 (2015). Together with reference 222, this report describes the importance of polyneuropathy as one of the most severe complications of diphtheria due to the spread of the toxin. […] Havaldar, P. V., Sankpal, M. N. Doddannavar, R. P. Diphtheritic myocarditis: clinical and laboratory parameters of prognosis and fatal outcome. Ann. Trop. Paediatr. 20, 209215 (2016).
#25 Corynebacterium Diphtheriae (Diptheria) – MD Searchlight
https://mdsearchlight.com/infectious-disease/corynebacterium-diphtheriae-diptheria/
Diphtheria is a dangerous disease that primarily affects the upper respiratory tract and can be prevented with a vaccine. […] The death rate from diphtheria has not changed much over the past 100 years, staying steady around 10%. The main reason why patients with diphtheria die is due to heart-related problems, which 10-30% of diphtheria patients develop. Unfortunately, for those affected by these heart complications, the likelihood of death is around 50%. […] There are a number of factors that can affect the outcome of the disease. For example, whether the patient has been vaccinated, how long theyâve had symptoms, and when they were diagnosed can all influence how severe the disease becomes. […] One study from 2004, which looked at 154 Vietnamese children with diphtheria, found that an extensive pseudomembrane and bull neck appearance are both strong signs that the child may develop serious heart problems due to diphtheria and therefore have a worse prognosis.
#26 Novel Clinical Monitoring Approaches for Reemergence of Diphtheria Myocarditis, Vietnam – Volume 28, Number 2âFebruary 2022 – Emerging Infectious Diseases journal – CDC
https://wwwnc.cdc.gov/eid/article/28/2/21-0555_article
Diphtheria myocarditis occurs in 10%20% of respiratory diphtheria, although this figure is likely underestimated because cardiac screening is lacking in many endemic settings. […] The presence of a bull neck and the amount of pharyngeal pseudomembrane at admission are potential risk factors for cardiomyopathy. […] The utility of modern diagnostic and monitoring methods, such as invasive blood pressure monitoring, continuous ECG monitoring, and point-of-care echocardiography, could also improve diagnosis and management through earlier detection of cardiac dysfunction and subclinical rhythm disturbances. […] Ventricular ectopics at admission are predictive of poor outcomes. […] We therefore recommend continuing close hemodynamic monitoring until myocardial functional recovery can be visualized on echocardiographic examination. […] Serial point-of-care echocardiography, where available, together with serial ECGs and standard-of-care clinical monitoring, should be used in the treatment of all hospitalized patients with diphtheria myocarditis to enable timely intervention to mitigate severe and life-threatening consequences.
#27 Novel Clinical Monitoring Approaches for Reemergence of Diphtheria Myocarditis, Vietnam – Volume 28, Number 2âFebruary 2022 – Emerging Infectious Diseases journal – CDC
https://wwwnc.cdc.gov/eid/article/28/2/21-0555_article
Diphtheria myocarditis occurs in 10%20% of respiratory diphtheria, although this figure is likely underestimated because cardiac screening is lacking in many endemic settings. […] The presence of a bull neck and the amount of pharyngeal pseudomembrane at admission are potential risk factors for cardiomyopathy. […] The utility of modern diagnostic and monitoring methods, such as invasive blood pressure monitoring, continuous ECG monitoring, and point-of-care echocardiography, could also improve diagnosis and management through earlier detection of cardiac dysfunction and subclinical rhythm disturbances. […] Ventricular ectopics at admission are predictive of poor outcomes. […] We therefore recommend continuing close hemodynamic monitoring until myocardial functional recovery can be visualized on echocardiographic examination. […] Serial point-of-care echocardiography, where available, together with serial ECGs and standard-of-care clinical monitoring, should be used in the treatment of all hospitalized patients with diphtheria myocarditis to enable timely intervention to mitigate severe and life-threatening consequences.
#28 Novel Clinical Monitoring Approaches for Reemergence of Diphtheria Myocarditis, Vietnam – Volume 28, Number 2âFebruary 2022 – Emerging Infectious Diseases journal – CDC
https://wwwnc.cdc.gov/eid/article/28/2/21-0555_article
Diphtheria myocarditis occurs in 10%20% of respiratory diphtheria, although this figure is likely underestimated because cardiac screening is lacking in many endemic settings. […] The presence of a bull neck and the amount of pharyngeal pseudomembrane at admission are potential risk factors for cardiomyopathy. […] The utility of modern diagnostic and monitoring methods, such as invasive blood pressure monitoring, continuous ECG monitoring, and point-of-care echocardiography, could also improve diagnosis and management through earlier detection of cardiac dysfunction and subclinical rhythm disturbances. […] Ventricular ectopics at admission are predictive of poor outcomes. […] We therefore recommend continuing close hemodynamic monitoring until myocardial functional recovery can be visualized on echocardiographic examination. […] Serial point-of-care echocardiography, where available, together with serial ECGs and standard-of-care clinical monitoring, should be used in the treatment of all hospitalized patients with diphtheria myocarditis to enable timely intervention to mitigate severe and life-threatening consequences.
#29 A population-level analysis of armed conflict and diphtheria at the subnational level in the WHO African Region 2017â2024
https://pmc.ncbi.nlm.nih.gov/articles/PMC12046743/
Diphtheria has been re-emerging around the world at alarming rates, raising concerns about emergency preparedness, especially when global supplies of life-saving diphtheria antitoxin are insufficient. […] This exploratory analysis indicates that conflict-related fatalities are potentially helpful indicators of subnational diphtheria risk in countries in the WHO African region from 2017 to 2024. Further, it may be especially useful in cases where estimates of population-level diphtheria immunity are limited. […] The model with vaccine coverage as the outcome variable provides evidence to support the hypothesis that regions with a history of conflict have lower subsequent childhood vaccination coverage. […] The best-fitting model with diphtheria status as the outcome provides evidence supporting a strong relationship between historical conflict severity and subsequent diphtheria outbreaks, even when including random effects of each state and country and when accounting for childhood vaccine coverage estimates.
#30 A population-level analysis of armed conflict and diphtheria at the subnational level in the WHO African Region 2017â2024
https://pmc.ncbi.nlm.nih.gov/articles/PMC12046743/
Our results indicate that data on recent armed conflict may be helpful for public health response planning, particularly in areas with limited access to vaccination coverage data. […] We found that a local history of severe armed conflict, as assessed by the number of resulting fatalities, is associated with subsequent reports of diphtheria presence in Africa from 2017 to 2024 and should be considered as a potential early signal of increased outbreak risk.
#31
https://link.springer.com/article/10.1186/s44263-025-00156-8
Diphtheria has been re-emerging around the world at alarming rates, raising concerns about emergency preparedness, especially when global supplies of life-saving diphtheria antitoxin are insufficient. […] This exploratory analysis indicates that conflict-related fatalities are potentially helpful indicators of subnational diphtheria risk in countries in the WHO African region from 2017 to 2024. […] The best-fitting model also associated lower estimates of diphtheria risk in areas with high (80%) and low (25%) vaccine coverage, though this is possibly due to underreporting of the true burden of disease in low-resource settings. […] We found that a local history of severe armed conflict, as assessed by the number of resulting fatalities, is associated with subsequent reports of diphtheria presence in Africa from 2017 to 2024 and should be considered as a potential early signal of increased outbreak risk.
#32
https://link.springer.com/article/10.1186/s44263-025-00156-8
Evidence from our analyses supports hypotheses that conflict can increase the risk of diphtheria both through lower vaccination coverage as well as via an independent mechanism. […] Although high levels of childhood DTP3 vaccine coverage were protective against the presence of reported diphtheria cases, we found that the relationship was somewhat complex, with estimated diphtheria risk peaking around 50% DTP3 coverage. […] Because of this, we suggest that the history and severity of armed conflict may be an early indicator of increased risk of diphtheria if local vaccination coverage data are unavailable, as is often the case in low-resource settings.
#33 A population-level analysis of armed conflict and diphtheria at the subnational level in the WHO African Region 2017â2024
https://pmc.ncbi.nlm.nih.gov/articles/PMC12046743/
Our results indicate that data on recent armed conflict may be helpful for public health response planning, particularly in areas with limited access to vaccination coverage data. […] We found that a local history of severe armed conflict, as assessed by the number of resulting fatalities, is associated with subsequent reports of diphtheria presence in Africa from 2017 to 2024 and should be considered as a potential early signal of increased outbreak risk.
#34 Human antibodies neutralizing diphtheria toxin in vitro and in vivo | Scientific Reports
https://www.nature.com/articles/s41598-019-57103-5
Diphtheria is fatal in 5-10% of cases, but children under the age of five have a mortality rate of up to 20%. […] Treatment involves antibiotics to kill the bacteria (erythromycin or penicillin for 14 days) and administering of diphtheria antitoxin (DAT) to neutralize the effects of the toxin. […] The individual antibodies did not show a high level of neutralization, whereas all antibody pairs and the triple antibody combination resulted in a neutralization potency of 79 IU/mg. […] The neutralization efficacy of the scFv-Fcs and IgGs were first analyzed in vitro using the Vero cell toxin neutralization assay. […] The specific activity of the best neutralizing human monoclonal antibodies from our studies in the Vero cell TNT also exceeded (approximately 10-fold) the potency of a rat monoclonal antibody that was included in our study. […] The antibodies described here are promising candidates for future regulatory and clinical development as an alternative to equine DAT for diphtheria therapy.
#35 Human antibodies neutralizing diphtheria toxin in vitro and in vivo | Scientific Reports
https://www.nature.com/articles/s41598-019-57103-5
Diphtheria is fatal in 5-10% of cases, but children under the age of five have a mortality rate of up to 20%. […] Treatment involves antibiotics to kill the bacteria (erythromycin or penicillin for 14 days) and administering of diphtheria antitoxin (DAT) to neutralize the effects of the toxin. […] The individual antibodies did not show a high level of neutralization, whereas all antibody pairs and the triple antibody combination resulted in a neutralization potency of 79 IU/mg. […] The neutralization efficacy of the scFv-Fcs and IgGs were first analyzed in vitro using the Vero cell toxin neutralization assay. […] The specific activity of the best neutralizing human monoclonal antibodies from our studies in the Vero cell TNT also exceeded (approximately 10-fold) the potency of a rat monoclonal antibody that was included in our study. […] The antibodies described here are promising candidates for future regulatory and clinical development as an alternative to equine DAT for diphtheria therapy.
#36 Human antibodies neutralizing diphtheria toxin in vitro and in vivo | Scientific Reports
https://www.nature.com/articles/s41598-019-57103-5
Diphtheria is fatal in 5-10% of cases, but children under the age of five have a mortality rate of up to 20%. […] Treatment involves antibiotics to kill the bacteria (erythromycin or penicillin for 14 days) and administering of diphtheria antitoxin (DAT) to neutralize the effects of the toxin. […] The individual antibodies did not show a high level of neutralization, whereas all antibody pairs and the triple antibody combination resulted in a neutralization potency of 79 IU/mg. […] The neutralization efficacy of the scFv-Fcs and IgGs were first analyzed in vitro using the Vero cell toxin neutralization assay. […] The specific activity of the best neutralizing human monoclonal antibodies from our studies in the Vero cell TNT also exceeded (approximately 10-fold) the potency of a rat monoclonal antibody that was included in our study. […] The antibodies described here are promising candidates for future regulatory and clinical development as an alternative to equine DAT for diphtheria therapy.
#37 Novel Clinical Monitoring Approaches for Reemergence of Diphtheria Myocarditis, Vietnam – Volume 28, Number 2âFebruary 2022 – Emerging Infectious Diseases journal – CDC
https://wwwnc.cdc.gov/eid/article/28/2/21-0555_article
Diphtheria is a life-threatening, vaccine-preventable disease caused by toxigenic Corynebacterium bacterial species that continues to cause substantial disease and death worldwide, particularly in vulnerable populations. […] Severe diphtheria is usually associated with cardiac and neurologic complications because of the high affinity of diphtheria toxin with theses tissues. […] Antitoxin is considered the cornerstone of the prevention of severe complications and death and should be readily available. […] However, a global shortage of diphtheria antitoxin (DAT) is ongoing, which hinders availability in low-resource settings. […] Managing diphtheria includes early use of DAT and antibiotics. Mortality rates increase daily with delays in DAT administration, from 4.2% if the disease is treated in the first 2 days to 24% by the fifth day of illness.
#38 Corynebacterium Diphtheriae (Diptheria) – MD Searchlight
https://mdsearchlight.com/infectious-disease/corynebacterium-diphtheriae-diptheria/
The prognosis for Corynebacterium diphtheriae (Diphtheria) can vary depending on several factors, including vaccination status, duration of symptoms, and timing of diagnosis. Severe cases of diphtheria can lead to heart-related problems, which can be fatal in 10-30% of patients. Factors associated with a worse prognosis include the presence of an extensive pseudomembrane and bull neck appearance, evidence of heart inflammation on admission to the hospital, and an increased level of AST enzyme.
#39 Diphtheria – StatPearls – NCBI Bookshelf
https://www.ncbi.nlm.nih.gov/books/NBK560911/
The prognosis of diphtheria is influenced by several factors: […] High mortality rates are observed in individuals younger than 5 and those older than 40. […] Cases with an onset duration exceeding 4 days are associated with elevated mortality. […] Cardiovascular involvement, particularly atrioventricular and left bundle-branch blocks, is associated with a poor prognosis. […] Systemic involvement is a significant predictor of high mortality rates.
#40 Diphtheria – Symptoms & causes – Mayo Clinic
https://www.mayoclinic.org/diseases-conditions/diphtheria/symptoms-causes/syc-20351897
Diphtheria can be treated with medications. But in advanced stages, diphtheria can damage the heart, kidneys and nervous system. Even with treatment, diphtheria can be deadly, especially in children. […] With treatment, most people with diphtheria survive these complications, but recovery is often slow. Diphtheria is fatal about 5% to 10% of the time. Rates of death are higher in children under age 5 or adults older than age 40.